Glutamate and Neuropsychiatric Disorders
portes grátis
Glutamate and Neuropsychiatric Disorders
Current and Emerging Treatments
Pavlovic, Zoran M.
Springer Nature Switzerland AG
04/2022
600
Dura
Inglês
9783030874797
15 a 20 dias
1112
Descrição não disponível.
Treatments Against Glutamatergic Excitotoxicity in Ischemic Stroke.- Definitions and Concepts of Stress.- Role of Glutamatergic Neurotransmission in the Pathophysiology of Stress-Related Disorders and Chronic Stress Response.- Current Glutamatergic Treatments and Future Directions for Glutamate-Based Management of Chronic Stress and Stress-Related Disorders.- The Role of the Glutamate System in Posttraumatic Stress Disorder and Glutamate-Based Treatments.- Glutamate in Migraine Neurobiology and Treatment.- Astrocyte Glutamate Transporter EAAT2 in Alzheimer Dementia.- The Glutamatergic System as a Target for the Development of New Pharmacological Treatments of Bipolar Disorder.- CNS Glutamate in Impulsive Aggression.- Glutamatergic Treatments for Parkinsons' Disease.- The Modulation of Glutamatergic Signaling as a Potential Therapeutic Strategy for Major Depression.- Glutamate-Based Treatment for Amyotrophic Lateral Sclerosis/Motor Neuron Disease.- Modulation of Glutamate for Chronic Pain Management.- Pharmacological Role of Glutamate Transporters in Substance Use Disorders.- Glutamate in Multiple Sclerosis: From Pathophysiology to Treatments.- The Role of Glutamate Dysregulation in the Etiology of ADHD.- Glutamate, Glutamatergic Drugs and Schizophrenia.- Glutamate and Epilepsy: An Insight from Temporal Lobe Epilepsy.- Glutamate Function in Anxiety Disorders and OCD: Evidence from Clinical and Translational Studies.- Modulators of Glutamatergic Signaling as Potential Treatments for Autism Spectrum Disorders.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Aggression;Alzheimer's Disease;Amyotrophic Lateral Sclerosis;Attention Deficit Hyperactivity Disorder;Autism Spectrum Disease;Bipolar Disorders;Chronic Pain;Chronic Stress and Resilience;Drug Development;Epilepsy;Glutamate Signaling;Ischemic Stroke;Migraine;Multiple Sclerosis;Parkinson's Disease;Psychopharmacology;Schizophrenia
Treatments Against Glutamatergic Excitotoxicity in Ischemic Stroke.- Definitions and Concepts of Stress.- Role of Glutamatergic Neurotransmission in the Pathophysiology of Stress-Related Disorders and Chronic Stress Response.- Current Glutamatergic Treatments and Future Directions for Glutamate-Based Management of Chronic Stress and Stress-Related Disorders.- The Role of the Glutamate System in Posttraumatic Stress Disorder and Glutamate-Based Treatments.- Glutamate in Migraine Neurobiology and Treatment.- Astrocyte Glutamate Transporter EAAT2 in Alzheimer Dementia.- The Glutamatergic System as a Target for the Development of New Pharmacological Treatments of Bipolar Disorder.- CNS Glutamate in Impulsive Aggression.- Glutamatergic Treatments for Parkinsons' Disease.- The Modulation of Glutamatergic Signaling as a Potential Therapeutic Strategy for Major Depression.- Glutamate-Based Treatment for Amyotrophic Lateral Sclerosis/Motor Neuron Disease.- Modulation of Glutamate for Chronic Pain Management.- Pharmacological Role of Glutamate Transporters in Substance Use Disorders.- Glutamate in Multiple Sclerosis: From Pathophysiology to Treatments.- The Role of Glutamate Dysregulation in the Etiology of ADHD.- Glutamate, Glutamatergic Drugs and Schizophrenia.- Glutamate and Epilepsy: An Insight from Temporal Lobe Epilepsy.- Glutamate Function in Anxiety Disorders and OCD: Evidence from Clinical and Translational Studies.- Modulators of Glutamatergic Signaling as Potential Treatments for Autism Spectrum Disorders.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Aggression;Alzheimer's Disease;Amyotrophic Lateral Sclerosis;Attention Deficit Hyperactivity Disorder;Autism Spectrum Disease;Bipolar Disorders;Chronic Pain;Chronic Stress and Resilience;Drug Development;Epilepsy;Glutamate Signaling;Ischemic Stroke;Migraine;Multiple Sclerosis;Parkinson's Disease;Psychopharmacology;Schizophrenia
